Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

13.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.6K
Mitochondrial Membranes01:45

Mitochondrial Membranes

6.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
6.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.4K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Immune functions of neuroglia.

Frontiers in immunology·2026
Same author

Aberrant Potassium Handling by Astrocytes and Epileptic Seizures: A Synthetic Update.

Acta physiologica (Oxford, England)·2026
Same author

Mitochondria transfer in neurological disorders: the key role of neuroglia.

Molecular neurodegeneration·2026
Same author

Astrocytes as Histaminergic Gatekeepers of Anxiety: A New Pathway for Emotional Control.

Journal of neurochemistry·2026
Same author

Congratulations, JNC Turns 70!

Journal of neurochemistry·2026
Same author

Author Correction: Curing the brain: in search for new astrocyte-specific therapies.

Experimental & molecular medicine·2026

Related Experiment Video

Updated: May 10, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K

Cell-specific mitochondrial response in progressive supranuclear palsy.

Valerie Sackmann1, Nasna Nassir2, Satoshi Tanikawa1

  • 1Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.

Mitochondrion
|April 20, 2025
PubMed
Summary

Progressive supranuclear palsy (PSP) involves mitochondrial dysfunction, particularly affecting Complex I in neurons and astrocytes. This study reveals cell-specific patterns of mitochondrial impairment in PSP, differentiating it from other neurodegenerative diseases.

Keywords:
AstrogliaCell cultureMitochondriaProgressive supranuclear palsySingle-nuclei RNA sequencingTau

More Related Videos

Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

3.4K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.5K

Related Experiment Videos

Last Updated: May 10, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

3.4K
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.5K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Progressive supranuclear palsy (PSP) is a tauopathy linked to neurodegeneration.
  • Mitochondrial dysfunction is implicated in neurodegenerative diseases, but its role in PSP is unclear.
  • Understanding cellular mitochondrial changes in PSP is crucial for disease mechanisms.

Purpose of the Study:

  • To investigate cell-specific mitochondrial alterations in the motor cortex of PSP patients.
  • To identify transcriptomic changes related to mitochondrial function in different cell types in PSP.
  • To examine astrocytic tau pathology and its impact on mitochondria in PSP.

Main Methods:

  • Performed cell-specific morphometric analysis of mitochondrial markers in post-mortem brain tissues.
  • Utilized single-nuclear transcriptomics to analyze gene expression in PSP and control samples.
  • Treated cultured astrocytes with PSP brain homogenates and analyzed tau pathology.

Main Results:

  • PSP brains showed significant mitochondrial changes in neurons and astrocytes, especially Complex I damage.
  • Glial cells upregulated mitochondrial function pathways, while neurons downregulated them, indicating impaired function.
  • Cultured astrocytes with tau pathology exhibited mitochondrial clumping, suggesting impaired neuron support.

Conclusions:

  • PSP is characterized by selective Complex I damage and cell-type-specific mitochondrial dysfunction.
  • Distinct transcriptomic responses in glial cells and neurons highlight differential mitochondrial impact.
  • Astrocytic tau pathology contributes to mitochondrial abnormalities, potentially impairing neuronal support in PSP.